# Bristol Myers Squibb Co: Form 8-K, filed Nov 13, 2023

- Company: [Bristol Myers Squibb Co](/companies/bmy.md) (CIK 14272)
- Form: 8-K
- Filed: 2023-11-13
- Accepted by EDGAR: Nov 13, 2023, 16:19 ET
- Period: 2023-10-30
- Accession: 0001140361-23-052908
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/14272/000114036123052908/ny20014138x1_8k.htm

Filed Nov 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-052908. Last ingested by Listed: Nov 6, 2026, 17:19 ET. No prices; not investment advice.
